|
EP1533617A1
|
|
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
|
|
AU2003287949A1
|
|
Synthetic chemokines labeled at selected positions
|
|
AU2003238892A8
|
|
Secretory signal sequences and uses thereof
|
|
EP1476465A1
|
|
Method for producing interferon
|
|
PL364932A1
|
|
Process for folding chemically synthesized polypeptides
|
|
WO0188140A1
|
|
Polypeptide involved in cell adhesion and phagocytosis and its use in treatment
|
|
IL146873D0
|
|
USE OF THE REGULATORY SUBUNIT OF THE cAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
|
|
US6573059B1
|
|
Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
|
|
CN1355843A
|
|
Vascular adhesion molecules and modulation of their function
|
|
AU2805700A
|
|
Malaria vaccine
|
|
US6482607B1
|
|
Expression vector for use in a one-step purification protocol
|
|
CZ80499A3
|
|
Modification process of polypeptides
|
|
EP0827966A1
|
|
Preparation of purified (poly) peptides
|
|
CN1187851A
|
|
Modified polypeptides for enhanced immunogenicity
|
|
US5736358A
|
|
Dictyostelid expression vector and method for expressing a desired protein
|
|
US6113917A
|
|
Modified polypeptides for enhanced immunogenicity
|
|
US6596278B2
|
|
Immunological response potentiation process
|
